» Articles » PMID: 18313916

Role of FDG PET in the Management of Childhood Lymphomas--case Proven or is the Jury Still Out?

Overview
Journal Eur J Cancer
Specialty Oncology
Date 2008 Mar 4
PMID 18313916
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Positron emission tomography (PET) is a novel non invasive functional imaging modality that is increasingly used for the primary staging of lymphomas and assessment of therapeutic response. This review evaluates the published reports of its use in childhood lymphomas, particularly in the primary staging, response assessment and monitoring after completion of treatment. Specific attention is focused on the clinical circumstances in which FDG PET is most likely to have an impact on management and some indications for its use in childhood lymphomas are suggested.

Citing Articles

FDG PET in response evaluation of bulky masses in paediatric Hodgkin's lymphoma (HL) patients enrolled in the Italian AIEOP-LH2004 trial.

Lopci E, Mascarin M, Piccardo A, Castello A, Elia C, Guerra L Eur J Nucl Med Mol Imaging. 2018; 46(1):97-106.

PMID: 30219963 DOI: 10.1007/s00259-018-4155-4.


PET/CT predicts bone marrow involvement in paediatric non-Hodgkin lymphoma and may preclude the need for bone marrow biopsy in selected patients.

Chen S, Wang S, He K, Ma C, Fu H, Wang H Eur Radiol. 2018; 28(7):2942-2950.

PMID: 29383519 DOI: 10.1007/s00330-018-5306-5.


International Pediatric Non-Hodgkin Lymphoma Response Criteria.

Sandlund J, Guillerman R, Perkins S, Pinkerton C, Rosolen A, Patte C J Clin Oncol. 2015; 33(18):2106-11.

PMID: 25940725 PMC: 4461807. DOI: 10.1200/JCO.2014.59.0745.


Revised International Pediatric Non-Hodgkin Lymphoma Staging System.

Rosolen A, Perkins S, Pinkerton C, Guillerman R, Sandlund J, Patte C J Clin Oncol. 2015; 33(18):2112-8.

PMID: 25940716 PMC: 4461808. DOI: 10.1200/JCO.2014.59.7203.


The role of FDG-PET/CT in the evaluation of residual disease in paediatric non-Hodgkin lymphoma.

Bhojwani D, McCarville M, Choi J, Sawyer J, Metzger M, Inaba H Br J Haematol. 2014; 168(6):845-53.

PMID: 25382494 PMC: 4351138. DOI: 10.1111/bjh.13219.